Health Condition 1: D3A8- Other benign neuroendocrine tumors
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with lateral skull base tumors who have been surgically treated over the past 10 years (Retrospective cohort) 2. Patients with lateral skull base tumors who will be surgically operated till June 2025 (prospective cohort) 3. Patients and attendants consenting for inclusion in the study.
Exclusion criteria
Exclusion criteria: 1. Patients with neurological deficits unrelated to lateral skull base tumors. 2. Patients and attendants not giving consent for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcomes in terms of residual disease Quality of life Speech and swallowing outcomes Cranial nerve function Timepoint: Prospective - at the time of surgery, 1 week and every 6 months. Retrospective - at the time of recruitment and every 6 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Retrospective - To compare preoperative & postoperative quality of life in patientsTimepoint: At the time of recruitment & every 6 months. | — |
Countries
India
Contacts
AIIMS Delhi